|
End-of-day quote
Palestine Exchange
|
||
| - | - |
|
| 08-13 | Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-30 | Jerusalem Pharmaceuticals Announces Board Changes | CI |
| Market Cap | 128M 128M 110M 103M 94.31M 177M 12.16B 178M 1.22B 476M 6.17B 480M 469M 20.42B | P/E 2024 |
13.7x | P/E 2025 | 8.13x |
|---|---|---|---|---|---|
| Enterprise Value | 117M 117M 101M 94.51M 86.27M 162M 11.12B 163M 1.12B 436M 5.64B 439M 429M 18.68B | EV / Sales 2024 |
1.47x | EV / Sales 2025 | 1.47x |
| Free-Float |
35.74% | Yield 2024 |
2.09% | Yield 2025 | 3.26% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2013-06-30 | |
Mohammed Natour
DFI | Director of Finance/CFO | - | 2020-02-29 |
Lina Masrouji
CTO | Chief Tech/Sci/R&D Officer | - | 1988-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 91 | - | |
Nidal Kamal
BRD | Director/Board Member | - | - |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.45% | +1.47% | +23.97% | +74.35% | 50.05B | ||
| +1.59% | +1.97% | +56.92% | +124.49% | 40.29B | ||
| -0.80% | +4.53% | +16.42% | +84.36% | 12.17B | ||
| +0.06% | -1.79% | -11.03% | +12.29% | 11.96B | ||
| +0.19% | -.--% | +29.35% | +150.00% | 9.25B | ||
| -1.80% | -1.50% | +25.41% | +48.78% | 7.62B | ||
| -0.15% | +3.78% | +28.77% | +223.54% | 7.36B | ||
| +1.47% | +1.72% | +45.98% | -9.98% | 7.21B | ||
| -0.84% | -2.36% | -36.62% | +16.04% | 5.26B | ||
| Average | -0.24% | +2.12% | +19.91% | +80.43% | 16.8B | |
| Weighted average by Cap. | -0.42% | +1.34% | +28.95% | +88.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 39.82M 39.82M 34.29M 32.19M 29.39M 55.21M 3.79B 55.6M 381M 148M 1.92B 150M 146M 6.36B | 48.95M 48.95M 42.14M 39.57M 36.12M 67.86M 4.66B 68.34M 469M 182M 2.36B 184M 180M 7.82B |
| Net income | 5.04M 5.04M 4.34M 4.07M 3.72M 6.98M 479M 7.03M 48.26M 18.78M 243M 18.92M 18.5M 805M | 10.18M 10.18M 8.77M 8.23M 7.51M 14.12M 969M 14.22M 97.55M 37.96M 491M 38.23M 37.4M 1.63B |
| Net Debt | -10.32M -10.32M -8.89M -8.34M -7.62M -14.31M -982M -14.41M -98.88M -38.47M -498M -38.76M -37.91M -1.65B | -10.9M -10.9M -9.38M -8.81M -8.04M -15.11M -1.04B -15.22M -104M -40.62M -526M -40.91M -40.02M -1.74B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















